1. Home
  2. TXG vs HTFL Comparison

TXG vs HTFL Comparison

Compare TXG & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$23.76

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

HTFL

Heartflow Inc.

HOLD

Current Price

$29.51

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
HTFL
Founded
2012
2007
Country
United States
United States
Employees
N/A
843
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TXG
HTFL
Price
$23.76
$29.51
Analyst Decision
Hold
Strong Buy
Analyst Count
15
5
Target Price
$20.25
$38.20
AVG Volume (30 Days)
2.5M
1.0M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
76.97
N/A
EPS
N/A
N/A
Revenue
$245,893,000.00
N/A
Revenue This Year
N/A
$27.66
Revenue Next Year
$7.33
$23.55
P/E Ratio
N/A
N/A
Revenue Growth
68.06
N/A
52 Week Low
$8.31
$20.13
52 Week High
$26.45
$41.22

Technical Indicators

Market Signals
Indicator
TXG
HTFL
Relative Strength Index (RSI) 58.02 52.34
Support Level $19.68 $28.60
Resistance Level $26.45 $32.71
Average True Range (ATR) 1.38 1.92
MACD 0.28 -0.25
Stochastic Oscillator 73.01 62.61

Price Performance

Historical Comparison
TXG
HTFL

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Share on Social Networks: